Swiss dental implant makers Straumann (STMN.S) and Nobel Biocare (NOBN.VX) are out of the race for AstraZeneca's (AZN.L) rival business, leaving a reduced field of bidders, people familiar with the situation said. Drugmaker AstraZeneca is looking to sell Astra Tech, its Molndal, Sweden-based maker of dental implants and medical devices, which it hopes could fetch around $2 billion. Second round offers are due on June 6, the people said. A spokesman for Nobel Biocare confirmed that the group is no longer interested in acquiring Astra Tech's business. Straumann declined to comment.
Source
